Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods for preparing 5-Aza-2'-deoxycytidine and intermediate product thereof

A technology for deoxycytidine and azacytosine, which is applied in the field of preparing the new azacytidine deoxynucleoside and intermediates for the preparation of 5-aza-2′-deoxycytidine, which can solve the problem that is not suitable for industrial production Expensive problems such as development, raw materials, protective groups and catalysts, etc., to achieve the effect of good reproducibility, low content and simple process

Inactive Publication Date: 2009-11-04
NANJING CHANGAO PHARMA SCI & TECH CO LTD
View PDF1 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] Usually, laboratories also commonly use the method of preparing 2'-deoxynucleosides by removing the oxygen atom at the 2'-position of the existing nucleoside sugar ring. In theory, it is also possible to remove the 2 '-oxygen atom to synthesize 5-aza-2'-deoxycytosine (European Journal of Medicinal Chemistry, 35(11), 1011-1019, 2000), but the price of raw materials, protecting groups and catalysts used in this method Relatively expensive, relatively unsuitable for industrial production and development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for preparing 5-Aza-2'-deoxycytidine and intermediate product thereof
  • Methods for preparing 5-Aza-2'-deoxycytidine and intermediate product thereof
  • Methods for preparing 5-Aza-2'-deoxycytidine and intermediate product thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Preparation of 1-(2'-deoxy-3',5'-di-O-p-chlorobenzoyloxy-D-arabinofuranosyl)-5-azacytosine

[0043] Weigh 313.6 g of 5-azacytosine, put it in a reaction flask, add 8 L of hexamethyldisilazane, stir, add 200 ml of trimethylchlorosilane, protect it under nitrogen, heat to reflux, react for 24 hours, and dissolve the raw materials. After the reaction was completed, the solvent was evaporated to dryness under reduced pressure by heating to obtain silanized 5-azacytosine, and the following reactions were carried out continuously without treatment.

[0044] Add silanized 5-azacytosine to 16L of 1,2-dichloroethane, stir to dissolve, add 1-chloro-3,5-di-O-p-chlorobenzoyl-2-deoxy-D-ribose 395.6g (0.92mol), cooled to 5°C, temperature-controlled addition of a mixture of 333.6ml of trimethylsilyl trifluoromethanesulfonate (TMSOTf) and 2L of acetonitrile, and reacted at room temperature for 3.5h.

[0045] Pour the reaction solution into 30L of cold water, extract twice with dichlor...

Embodiment 2

[0052] Preparation of 5-aza-2'-deoxycytidine

[0053] Put 100L of methanol in a reaction flask, add 16 grams of sodium methoxide, stir, and add 1-(2'-deoxy-3',5'-di-O-p-chlorobenzoyloxy-D in Example 1 -Arabinofuranosyl)-5-azacytosine 510 grams, reacted at room temperature for 20 hours, concentrated to an appropriate volume, left to cool, filtered, washed with methanol, and dried in vacuo to obtain 150 grams of white crystal product, the related substances determined by HPLC were less than 1.5% .

[0054] Methanol was recrystallized again, as determined by HPLC, the related substance was 0.5%.

[0055] mp: 191.1-193.2;

[0056] [α] D 22 =+68.1° (30min), +57.8° (6hr) (c=0.5, H2O).

[0057] MS[M+H]+: 228.09;

[0058] Elemental analysis C8H12N4O4: theoretical C42.10, H5.30, N, 24.55, measured C42.02, H5.33, N, 24.35;

[0059] 1HNMR test (DMSO-d6) δ: 2.13~2.21(m, 2H), 3.54-3.61(m, 2H), 3.82(t, 1H), 4.24(m, 1H), 5.01(m, 2H), 5.20( d, 1H), 6.03 (t, 1H), 7.47 (s, 2H), 8.51 (s,...

Embodiment 3

[0062] Preparation of α-isomer of 2'-deoxy-5-azacytosine nucleoside

[0063] The mother liquor of 5-aza-2'-deoxycytidine prepared by the method of Reference Example 2 was subjected to column chromatography (gradient elution of chloroform-methanol system), and the fraction containing the α-isomer was collected and recrystallized from a mixed solvent of methanol / ether to obtain The alpha isomer of 5-aza-2'-deoxycytidine was used as white powder crystals.

[0064] 1HNMR (DMSO-d6): 8.26 (s, 1, H6), 7.4 (e, 2, NH2), 5.94 (d, 1, H1'), 5.21 (d, 1, OH3'), 4.83 (t, 1 , OH5'), 4.25(m, 2, H3', 4'), 3.4(m, 2, H5'), 2.3(m, 2, H-2');

[0065] Mp: Decompose at 181-182°C.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to methods for preparing 5-Aza-2'-deoxycytidine and an intermediate product thereof. The method for preparing the preparing 5-Aza-2'-deoxycytidine comprises the following steps: a compound (shown in formula 2) is hydrolyzed under alkaline matter to remove acyl-oxygen protecting group, a diastereomeric compound (shown in formula 3) is obtained, and then the diastereomeric compound is separated by a general separation technology to obtain an isomer. The invention also relates to a compound (shown in formula 2) used as the intermediate product and a preparation method thereof, wherein the preparation method comprises the following steps: 5-Aza cytimidine is activated by a silanization method, and then makes displacement reaction with a compound (shown in formula 4), and further removes the protecting group to obtain the compound (shown in formula 2). The preparation method has simpler process, good reproduction quality and little toxicity and is suitable to the industrialized production; and meanwhile, used raw materials and reagent are easy to obtain.

Description

technical field [0001] The present invention relates to a preparation method of 5-aza-2'-deoxycytidine, and relates to a new azacytidine deoxynucleoside, which is an intermediate for preparing 5-aza-2'-deoxycytidine , and also relates to a method for preparing the novel azacytosine deoxynucleoside. Background technique [0002] 5-Aza-2′-deoxycytidine, namely decitabine, chemical name: 4-amino-1-(2-deoxy-β-D-erythro-ribofuranose)-1, 3,5-Triazin-2(1H)-one is a drug developed by SuperGen Corporation of the United States for the treatment of myelodysplastic syndrome and the like. The molecular structural formula of 5-aza-2'-deoxycytidine is shown in Formula 1 below: [0003] [0004] As a specific DNA methyltransferase inhibitor, decitabine can reverse the methylation process of DNA, induce tumor cells to differentiate into normal cells or induce tumor cell apoptosis. In tumor cells, decitabine is phosphorylated by deoxycytidine kinase and binds to DNA in the form of phosp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H19/073A61P43/00
CPCY02P20/55
Inventor 姜力勋储刚王正泽黄海燕李纬
Owner NANJING CHANGAO PHARMA SCI & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com